Russian researchers have discovered that the modified protein 'CRYAB', which accumulates in the cells of diabetes patients, plays an active role. This protein contributes to the development of the disease's complications. Scientists believe that studying the mechanisms of CRYAB's action could lead to the development of new treatment methods. 'Our findings open new perspectives in the fight against diabetic complications,' the authors of the study stated. They emphasized the importance of further research in this area.
